Skip to content

Analysis of gene mutations and clinical response and mechanisms of leukemogenesis in acute leukemia

Analysis of gene mutations and clinical response and mechanisms of leukemogenesis in acute leukemia - Hokkaido Leukemia Net

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048611
Enrollment
1500
Registered
2022-08-08
Start date
2016-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute leukemia

Interventions

None listed

Sponsors

Hokkaido University Hospital Department of Hematology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) a patient clinically suspected acute leukemia 2) age equal or more than 16 3) a patient who agree to preserve specimen 4) a patient who agree to register this trial

Exclusion criteria

Exclusion criteria: 1) a patient whose leukemic genome DNA or cDNA is not available 2) a patient who is considered as inappropriate to register this trial

Design outcomes

Primary

MeasureTime frame
Overall survival

Secondary

MeasureTime frame
Relapse free survival

Countries

Japan

Contacts

Public ContactMasahiro Onozawa

Hokkaido University Hospital Department of Hematology

onozawa@med.hokudai.ac.jp+81-11-706-7214

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026